Microvascular effects of Photofrin®-induced photodynamic therapy

Cheng Jen Chang, Sally M.H. Cheng, J. Stuart Nelson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and objective: The object of our study is to evaluate the feasibility of photodynamic therapy (PDT) for complicated hemangiomas. The photosensitizing activities of Photofrin® have been used in vivo models for our goal of evaluation. Study design/materials and methods: The in vivo biological activities of Photofrin® exposed to the total laser energy density of 100 J/cm2 with the power density of 100 or 120 mW/cm2 at 630 nm wavelength was studied. The amount of vascular damage produced in the chick chorioallantoic membrane (CAM) was evaluated. At 630 nm wavelength, those individual vessels with a diameter of 40 μm or less and those with a diameter between 40 and 100 μm were treated with Photofrin® at a concentration of about 2.5 mg/mL, and injected intraperitoneally at 2.5 mg/kg, illuminated at 100 and 120 mW/cm2, respectively. Both exhibited coagulation. Results: There were no statistically significant differences between the two groups (100 and 120 mW/cm2) on vessel damage grade 1. With vessel damage grades 2 and 3, the differences were statistically significant between two groups. Vessel damages between arterioles and venules also demonstrated differences in the 100 mW/cm2 treated group but not in the 120 mW/cm2 group. Statistically significant differences were also shown in arteriole and venules damage between 100 and 120 mW/cm2 treated groups. The severity of vessel damage between grades 1 and 2, 1 and 3, and 2 and 3, were compared. The differences were statistically significant in 100 mW/cm2 treated group. There was no statistically significant difference in 120 mW/cm2 treated group. Conclusion: Photofrin® has the capabilities for destruction of microvascular vessels of CAM. Extension of this study to the second-generation photosensitizers is underway. The most important treatment variables seem to be the power density.

Original languageEnglish
Pages (from-to)95-99
Number of pages5
JournalPhotodiagnosis and Photodynamic Therapy
Volume4
Issue number2
DOIs
Publication statusPublished - Jun 1 2007
Externally publishedYes

Fingerprint

Dihematoporphyrin Ether
Photochemotherapy
Chorioallantoic Membrane
Venules
Arterioles
Photosensitizing Agents
Hemangioma
Blood Vessels
Lasers

Keywords

  • Chick chorioallantoic membrane
  • Photodynamic therapy
  • Photofrin

ASJC Scopus subject areas

  • Biophysics
  • Oncology
  • Dermatology
  • Pharmacology (medical)

Cite this

Microvascular effects of Photofrin®-induced photodynamic therapy. / Chang, Cheng Jen; Cheng, Sally M.H.; Nelson, J. Stuart.

In: Photodiagnosis and Photodynamic Therapy, Vol. 4, No. 2, 01.06.2007, p. 95-99.

Research output: Contribution to journalArticle

Chang, Cheng Jen ; Cheng, Sally M.H. ; Nelson, J. Stuart. / Microvascular effects of Photofrin®-induced photodynamic therapy. In: Photodiagnosis and Photodynamic Therapy. 2007 ; Vol. 4, No. 2. pp. 95-99.
@article{41eb233326294d20b5426cf7d3e42df6,
title = "Microvascular effects of Photofrin{\circledR}-induced photodynamic therapy",
abstract = "Background and objective: The object of our study is to evaluate the feasibility of photodynamic therapy (PDT) for complicated hemangiomas. The photosensitizing activities of Photofrin{\circledR} have been used in vivo models for our goal of evaluation. Study design/materials and methods: The in vivo biological activities of Photofrin{\circledR} exposed to the total laser energy density of 100 J/cm2 with the power density of 100 or 120 mW/cm2 at 630 nm wavelength was studied. The amount of vascular damage produced in the chick chorioallantoic membrane (CAM) was evaluated. At 630 nm wavelength, those individual vessels with a diameter of 40 μm or less and those with a diameter between 40 and 100 μm were treated with Photofrin{\circledR} at a concentration of about 2.5 mg/mL, and injected intraperitoneally at 2.5 mg/kg, illuminated at 100 and 120 mW/cm2, respectively. Both exhibited coagulation. Results: There were no statistically significant differences between the two groups (100 and 120 mW/cm2) on vessel damage grade 1. With vessel damage grades 2 and 3, the differences were statistically significant between two groups. Vessel damages between arterioles and venules also demonstrated differences in the 100 mW/cm2 treated group but not in the 120 mW/cm2 group. Statistically significant differences were also shown in arteriole and venules damage between 100 and 120 mW/cm2 treated groups. The severity of vessel damage between grades 1 and 2, 1 and 3, and 2 and 3, were compared. The differences were statistically significant in 100 mW/cm2 treated group. There was no statistically significant difference in 120 mW/cm2 treated group. Conclusion: Photofrin{\circledR} has the capabilities for destruction of microvascular vessels of CAM. Extension of this study to the second-generation photosensitizers is underway. The most important treatment variables seem to be the power density.",
keywords = "Chick chorioallantoic membrane, Photodynamic therapy, Photofrin",
author = "Chang, {Cheng Jen} and Cheng, {Sally M.H.} and Nelson, {J. Stuart}",
year = "2007",
month = "6",
day = "1",
doi = "10.1016/j.pdpdt.2007.03.003",
language = "English",
volume = "4",
pages = "95--99",
journal = "Photodiagnosis and Photodynamic Therapy",
issn = "1572-1000",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Microvascular effects of Photofrin®-induced photodynamic therapy

AU - Chang, Cheng Jen

AU - Cheng, Sally M.H.

AU - Nelson, J. Stuart

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Background and objective: The object of our study is to evaluate the feasibility of photodynamic therapy (PDT) for complicated hemangiomas. The photosensitizing activities of Photofrin® have been used in vivo models for our goal of evaluation. Study design/materials and methods: The in vivo biological activities of Photofrin® exposed to the total laser energy density of 100 J/cm2 with the power density of 100 or 120 mW/cm2 at 630 nm wavelength was studied. The amount of vascular damage produced in the chick chorioallantoic membrane (CAM) was evaluated. At 630 nm wavelength, those individual vessels with a diameter of 40 μm or less and those with a diameter between 40 and 100 μm were treated with Photofrin® at a concentration of about 2.5 mg/mL, and injected intraperitoneally at 2.5 mg/kg, illuminated at 100 and 120 mW/cm2, respectively. Both exhibited coagulation. Results: There were no statistically significant differences between the two groups (100 and 120 mW/cm2) on vessel damage grade 1. With vessel damage grades 2 and 3, the differences were statistically significant between two groups. Vessel damages between arterioles and venules also demonstrated differences in the 100 mW/cm2 treated group but not in the 120 mW/cm2 group. Statistically significant differences were also shown in arteriole and venules damage between 100 and 120 mW/cm2 treated groups. The severity of vessel damage between grades 1 and 2, 1 and 3, and 2 and 3, were compared. The differences were statistically significant in 100 mW/cm2 treated group. There was no statistically significant difference in 120 mW/cm2 treated group. Conclusion: Photofrin® has the capabilities for destruction of microvascular vessels of CAM. Extension of this study to the second-generation photosensitizers is underway. The most important treatment variables seem to be the power density.

AB - Background and objective: The object of our study is to evaluate the feasibility of photodynamic therapy (PDT) for complicated hemangiomas. The photosensitizing activities of Photofrin® have been used in vivo models for our goal of evaluation. Study design/materials and methods: The in vivo biological activities of Photofrin® exposed to the total laser energy density of 100 J/cm2 with the power density of 100 or 120 mW/cm2 at 630 nm wavelength was studied. The amount of vascular damage produced in the chick chorioallantoic membrane (CAM) was evaluated. At 630 nm wavelength, those individual vessels with a diameter of 40 μm or less and those with a diameter between 40 and 100 μm were treated with Photofrin® at a concentration of about 2.5 mg/mL, and injected intraperitoneally at 2.5 mg/kg, illuminated at 100 and 120 mW/cm2, respectively. Both exhibited coagulation. Results: There were no statistically significant differences between the two groups (100 and 120 mW/cm2) on vessel damage grade 1. With vessel damage grades 2 and 3, the differences were statistically significant between two groups. Vessel damages between arterioles and venules also demonstrated differences in the 100 mW/cm2 treated group but not in the 120 mW/cm2 group. Statistically significant differences were also shown in arteriole and venules damage between 100 and 120 mW/cm2 treated groups. The severity of vessel damage between grades 1 and 2, 1 and 3, and 2 and 3, were compared. The differences were statistically significant in 100 mW/cm2 treated group. There was no statistically significant difference in 120 mW/cm2 treated group. Conclusion: Photofrin® has the capabilities for destruction of microvascular vessels of CAM. Extension of this study to the second-generation photosensitizers is underway. The most important treatment variables seem to be the power density.

KW - Chick chorioallantoic membrane

KW - Photodynamic therapy

KW - Photofrin

UR - http://www.scopus.com/inward/record.url?scp=34248186556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248186556&partnerID=8YFLogxK

U2 - 10.1016/j.pdpdt.2007.03.003

DO - 10.1016/j.pdpdt.2007.03.003

M3 - Article

AN - SCOPUS:34248186556

VL - 4

SP - 95

EP - 99

JO - Photodiagnosis and Photodynamic Therapy

JF - Photodiagnosis and Photodynamic Therapy

SN - 1572-1000

IS - 2

ER -